|
Oct 18
|
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
|
|
Oct 18
|
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
|
|
Oct 16
|
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
|
|
Sep 16
|
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
|
|
Aug 14
|
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
|
|
Aug 6
|
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
|
|
Aug 1
|
Phio Pharmaceuticals Announces New Chief Financial Officer
|
|
May 15
|
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
|
|
May 9
|
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
|
|
Apr 30
|
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
|
|
Apr 22
|
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
|
|
Apr 16
|
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
|
|
Apr 11
|
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
|
|
Apr 3
|
National Spotlight Features Phio’s Innovative RNAi Technology Platform
|
|
Apr 2
|
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
|
|
Mar 21
|
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
|
|
Mar 13
|
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
|
|
Mar 6
|
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
|
|
Dec 7
|
Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
|